Bonduelle - Résultats annuels 2025-2026 : Le Groupe Bonduelle confirme sa résilience et clôture son exercice 2025-2026 sur un chiffre d’affaires et une rentabilité stables

Bonduelle reported FY2025-26 revenue of €2.186bn, down 0.8% reported but up 0.4% on a like-for-like basis, while recurring operating profit declined 5.0% to €79.6m and the margin contracted 16bps to 3.6%. Net profit improved to €16.2m from a €11.5m loss, largely supported by a €33.1m contribution from discontinued operations, despite a €35m goodwill impairment at Bonduelle Americas and €47.3m of non-recurring charges. Operating cash flow rose 27.5% to €98.9m, but net debt increased to €577.4m and leverage rose to 3.58x; management is prioritizing cash generation, profitability and deleveraging amid agricultural and geopolitical uncertainty.

Analysis

BON’s reported profit recovery is low-quality for equity valuation: it is driven by discontinued operations and working-capital release, while recurring earnings capacity weakened and the core business remains constrained by low single-digit margins. The impairment establishes that the North American fresh platform is earning below its carrying-value assumptions; absent a disclosed divestiture or credible turnaround plan, this raises the probability of further restructuring cash costs and limits any near-term re-rating.

The inventory draw is supportive for liquidity over the next 1-3 months, but it has a mechanical trade-off: lower factory utilization has already offset cost-saving benefits. With leverage elevated relative to a defensive packaged-food peer group, management’s priority will likely be deleveraging rather than brand investment, acquisitions, or meaningful shareholder returns. The proposed dividend should not be interpreted as evidence of sustainable free-cash-flow expansion.

European canned-food recovery may prove less durable than investors assume if trade protection restores volumes but also leaves retailer bargaining power intact. In North America, raw-material volatility and a weaker fresh-product franchise create an opening for better-scaled branded food competitors such as Conagra (CAG), Campbell’s (CPB), and Kraft Heinz (KHC) to defend shelf space and promotional intensity. The relevant catalyst is the November sales release: stabilization in North America and sequential margin recovery would challenge the bearish view; another volume-led decline would make FY27 deleveraging targets increasingly difficult.

Contrarianly, BON’s small free float and depressed expectations could produce a sharp tactical bounce if inventory normalization converts into sustained cash generation and management signals additional asset sales. That is not yet an investable fundamental long: net debt must begin declining, recurring operating margin must recover above the current level, and the Americas impairment must not be followed by another guidance reset. This is primarily a balance-sheet and execution story, not a consumer-staples growth rerating.

Key Decisions for Investors

• Maintain an underweight/short bias in BON over the next 1-3 months, preferably sized modestly given liquidity and controlling-family dynamics. Thesis trigger: November revenue shows continued North American contraction or European price/mix deterioration; cover if management demonstrates sequential recurring-margin recovery and net debt reduction.
• Use a relative-value expression rather than an outright large short: long CAG or CPB / short BON, 3-6 month horizon. Larger peers offer greater procurement scale and less balance-sheet sensitivity to crop and energy shocks; reassess if BON announces a material Americas disposal at a valuation above implied carrying value.
• Do not underwrite the reported cash-flow improvement as recurring until FY27 capex, inventory days, and restructuring cash payments are disclosed. Set an alert for leverage above 3.75x or renewed goodwill impairment, either of which would increase refinancing and multiple-compression risk.
• Avoid treating the dividend as a catalyst. A tactical long is only warranted after evidence that the inventory release has not impaired service levels and recurring operating margin trends back above 3.8%; absent that, risk/reward favors waiting rather than buying post-results weakness.